《公司業績》大豐港(08310.HK)全年盈轉虧蝕7,347.2萬元 獨立核數師提出意見
大豐港(08310.HK)公佈截至去年12月底止全年業績,營業額9.08億元,按年跌55.5%。盈轉虧蝕7,347.2萬元,上年同期賺5.64億元;每股虧損5.7仙。不派息。
獨立核數師提出意見。集團於去年度自持續經營業務產生虧損7,073.8萬港元,於該日,集團的流動負債淨額及負債淨額分別約爲1.57億港元及4.4億港元。該等情況及綜合財務報表附註所載的其他事項顯示存在重大不確定性,或會對集團之持續經營能力產生重大懷疑,因此其可能無法在正常業務過程中變現其資產並清償其債務。經考慮集團採取於綜合財務報表附註2披露的措施後,董事認爲集團將有能力持續經營。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.